GlassScriptPhysician profile
Parham Yashar
NPI 1215100805
$19,778.62
in general payments reported to CMS, 2019-2025
28 companies · $7,886 in 2025
The $7,886 reported for 2025 was more than what 84% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,783 · 2020: $2,003 · 2021: $1,771 · 2022: $1,806 · 2023: $2,665 · 2024: $864 · 2025: $7,886.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,200 · Food and Beverage: $2,299 · Travel and Lodging: $1,916.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,200.00 |
| Food and Beverage | $2,299.32 |
| Travel and Lodging | $1,916.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Imperative Care, INC | $6,874.19 | 2020-2025 | Zoom 88-T Large Distal Platform, Zoom Rdl Radial Access System, 103cm, Zoom Reperfusion Catheter |
| Microvention, INC. | $2,852.76 | 2019-2022 | |
| Globus Medical, INC. | $2,418.45 | 2019-2025 | Excelsiusgps Robotic Navigation System, Excelsius Gps, Senza |
| Alphatec Spine, INC | $1,421.88 | 2020-2022 | |
| Centinel Spine, LLC | $1,125.00 | 2025 | Prodisc L |
| Medacta USA, INC. | $1,084.43 | 2020 | |
| Abbott Laboratories | $1,084.40 | 2022-2025 | Proclaim, Jot Dx, Aveir |
| Relievant Medsystems, INC. | $595.41 | 2019-2021 | |
| Nevro Corp. | $367.14 | 2020-2022 | |
| Depuy Synthes Sales INC. | $344.50 | 2019-2023 | Emboguard |
| Stryker Corporation | $330.84 | 2019-2024 | Adherus Autospray Dural Sealant, Universal Neuro 3 |
| Boston Scientific Corporation | $204.34 | 2019-2025 | Intracept |
| Highridge Medical LLC | $138.89 | 2024 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Baylis Medical Company INC | $136.20 | 2019 | |
| Medtronic, INC. | $133.68 | 2021-2024 | Solitaire X, Accurian |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carlsmed, INC. | $130.18 | 2022 | |
| Penumbra, INC. | $126.00 | 2019 | |
| Nuvasive, INC. | $110.20 | 2019-2021 | |
| Pfizer INC. | $44.62 | 2019 | |
| Si-Bone, INC. | $38.06 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $33.91 | 2019 | |
| Electronic Waveform Lab, INC. | $33.70 | 2022 | |
| Route 92 Medical, INC. | $32.84 | 2025 | |
| Asahi Intecc USA, INC. | $31.16 | 2020 | |
| Medtronic USA, INC. | $28.81 | 2019 | |
| Stimwave Technologies Incorporated | $22.50 | 2021 | |
| Abbvie INC. | $19.13 | 2019 | |
| Janssen Pharmaceuticals, INC | $15.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parham Yashar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.